Anti-SLC1A5/ASCT2 Rabbit Antibody [F12D14]

Catalog No.: F4045

    Application: Reactivity:

    Usage Information

    Dilution
    1:1000
    1:30
    1:1600
    1:50
    1:40
    Application
    WB, IP, IHC, IF, FCM
    Reactivity
    Human
    Source
    Rabbit
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    56 kDa

    Datasheet & SDS

    Biological Description

    Specificity
    Anti-SLC1A5/ASCT2 Rabbit Antibody [F12D14] detects endogenous levels of total SLC1A5/ASCT2 protein.
    Clone
    F12D14
    Synonym(s)
    ASCT2, M7V1, RDR, RDRC, SLC1A5, Neutral amino acid transporter B(0), ATB(0), Baboon M7 virus receptor, RD114/simian type D retrovirus receptor, Sodium-dependent neutral amino acid transporter type 2, Solute carrier family 1 member 5
    Background
    SLC1A5, also known as ASCT2 (Alanine-Serine-Cysteine Transporter 2), is a sodium-dependent neutral amino acid antiporter that plays a crucial role in transporting glutamine, a vital amino acid for rapidly proliferating cells, including those in cancer. ASCT2 belongs to the solute carrier family 1 (SLC1) and features transport and scaffold domains linked by a key ECL2a loop that facilitates conformational changes during the transport cycle. Both inward- and outward-facing conformations have been observed, with the HP2 loop serving as an extracellular gate that controls substrate access. ASCT2 functions through a Na+-dependent antiport mechanism, exchanging extracellular glutamine for intracellular neutral amino acids, which is vital for supporting cellular metabolism, mTORC1 pathway activation, T-cell function, and the proliferation of cancer cells. The transporter is highly expressed in tumors and inflammatory cells, correlating with increased glutamine uptake and enhanced tumor growth. Regulation of ASCT2 involves glycosylation at N163 and N212 for membrane stability and trafficking, along with scaffold protein interactions that modulate transport activity. Targeting SLC1A5 reduces tumor growth and impairing mTORC1 signaling.
    References
    • https://pubmed.ncbi.nlm.nih.gov/30234109/
    • https://pubmed.ncbi.nlm.nih.gov/31580259/

    Tech Support

    Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

    Handling Instructions

    Tel: +1-832-582-8158 Ext:3
    If you have any other enquiries, please leave a message.

    * Indicates a Required Field

    Please enter your name.
    Please enter your email. Please enter a valid email address.
    Please write something to us.